Financials data is unavailable for this security.
Cash flow in USDView more
In 2022, cash reserves at LianBio fell by 168.89m. Cash Flow from Financing totalled 1.71m or -- of revenues. In addition the company used 99.19m for operations while cash used for investing totalled 69.20m.
Cash flow per share | -0.8076 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.89 |
---|---|
Tangible book value per share | 1.89 |
More ▼
Balance sheet in USDView more
Current ratio | 10.06 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼